Fundraising Fox
Martin Schmieg
InvestorC-level executive at Boutique Venture Partners
Find your path to Martin
Sign up to see every warm intro you have to Martin
- Paths you didn't know you had: your email and LinkedIn already hold routes to Martin. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Martin Schmieg has 35 years of business experience across the global life sciences industry. He served as Chief Financial Officer for Cytometrics, Advanced Bionics, Sirna Therapeutics, and Isolagen. At Advanced Bionics he helped structure the company's $4.2 billion sale to Boston Scientific, and at Sirna Therapeutics he co-developed a strategic plan that led to its $1.3 billion acquisition by Merck & Co.
Invests in
Biotech
Colleagues at Boutique Venture Partners
Frequently asked questions
- Who is Martin Schmieg?
- Martin Schmieg has 35 years of business experience across the global life sciences industry. He served as Chief Financial Officer for Cytometrics, Advanced Bionics, Sirna Therapeutics, and Isolagen. At Advanced Bionics he helped structure the company's $4.2 billion sale to Boston Scientific, and at Sirna Therapeutics he co-developed a strategic plan that led to its $1.3 billion acquisition by Merck & Co.
- Where does Martin Schmieg work?
- Martin Schmieg is C-level executive at Boutique Venture Partners.
- What does Martin Schmieg invest in?
- Martin Schmieg invests in Biotech.
About this profile. Compiled from public sources — Boutique Venture Partners's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights